dc.description.abstract |
Introduction. COPD is a complex heterogeneous disease, characterized by persistent and progressive
airflow limitation with estimated prevalence ranging between 8 and 15 %. Acute worsening of clinical state
being associated with significant mortality making it the third leading cause of death worldwide and a true
socioeconomic burden. With each exacerbation, quality of life tends to worsen due to lung function decline
described by patients as aggravation of subjective and physical state that do not fully reflect patients
condition. The task of the medical community is to identify the right tools for assessing quality of life in
patients with multiple exacerbations in COPD.
Aim of study. Comparative assessment of the quality of life in frequent exacerbators and non- exacerbators
by using standard tools.
Material and methods. In this study were enrolled 67 patients with different COPD severity, hospitalized
during the period of 2012-2016. From each patient were collected anthropometric data, were evaluated
dyspnea severity via mMRC and lung function using Jaeger® Master Screen Body by measuring FVC,
FEV1, FEV1/FVC. Collected statistical data were processed by using Statistica 6.0 (Statsoft Inc).
Results. 55 (82%) men and 12 (18%) women with mean age of 62,3 ± 9,9 years participated in the research,
31 were included in non exacerbators group ( ≤ 1 exacerbations/ year ) and 36 in frequent exacerbators
group (≥ 2 exacerbation/ year). Comparative assessing of clinical markers depending on the rate of
exacerbation (age, weight, height, BMI, pack/year, mMRC) and mean results of quality of life measurement
tools (SGQR and CCQ) of both groups revealed a decline of quality of life in patients with multiple
exacerbations ( SGRQ-non exacerbators- 54,34 ± 14,18, frequent exacerbators- 65,84 ± 11,59 (p < 0,05);
CCQ non-exacerbators- 2,60 ± 0,64 , frequent exacerbators 3,05 ± 0,62 (p < 0,05);). 6MWD showed a
moderate correlation with exacerbation rate (r = -0,67 p < 0,05).
Conclusions: In COPD multiple exacerbations lead to decline in quality of life. Malleable exogenous
factors should be modified in order to reduce the rate of exacerbations. |
en_US |